dalteparin has been researched along with Fatty Liver in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Fatty Liver: Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Artico, M | 1 |
| Riganò, R | 1 |
| Buttari, B | 1 |
| Profumo, E | 1 |
| Ionta, B | 1 |
| Bosco, S | 1 |
| Rasile, M | 1 |
| Bianchi, E | 1 |
| Bruno, M | 1 |
| Fumagalli, L | 1 |
1 other study available for dalteparin and Fatty Liver
| Article | Year |
|---|---|
Protective role of parnaparin in reducing systemic inflammation and atherosclerotic plaque formation in ApoE-/- mice.
Topics: Animals; Apolipoproteins E; Arteries; Disease Models, Animal; Fatty Liver; Fibrinolytic Agents; Gene | 2011 |